This small-cap growth stock’s been flying in 2019 and I think there’s more to come

Paul Summers takes a closer look at the latest set of results from a market minnow that’s generating a lot of new interest from investors.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in small-cap science instrument designer and manufacturer Judges Scientific (LSE: JDG) were registering great gains in early trading this morning as the company revealed a very encouraging set of half-year results. 

Revenues rose 9% to a record £40.2m in the first half of 2019 with adjusted pre-tax profit jumping 27% to £8.4m. Judges’ net cash pile also continues to grow, hitting £7.2m by the end of June compared to £700,000 at the end of 2018.

The firm had £20.8m in cash at the end of interim period — £5.1m more than at the end of December. And while the market minnow is unlikely to currently attract yield-hungry investors, the fact the interim dividend was hiked by no less than 25% today is indicative of just how confident management is in its future

Indeed, buoyed by recent business and a decent order book (despite what chairman Alex Hambro described as a “subdued second quarter“), management now predicts adjusted pre-tax profits and earnings per share for the full year will be ahead of previous analyst expectations of £15m and 188.4p, respectively.  

Having already climbed 42% in value so far in 2019, Judges’ shares are clearly not the bargain they once were. On 18 times forecast earnings before today’s upgrade, I still think they warrant attention once traders have realised some profit, especially as returns on capital and free cash flow are also going in the right direction. 

Revenue up, share price down

Also revealing interim numbers this morning was gaming services provider Keywords Studios (LSE: KWS) — a company that was propelled to mid-cap status when its share price multi-bagged between 2016 and 2018.

Here, revenue jumped a little under 40% to €153.2m, thanks to an increase in demand across all of the company’s service lines (and a rise in the number of clients buying 3 or more of said services).

Adjusted pre-tax profit climbed 14.3% to €18.4m, although gross margin fell slightly to 36.1% (from 37.4%) as a result of investment in its recruitment, training and facilities around the world. The latter is expected to bounce back in the second half as the company is able to grow capacity and offer new services.

Like Judges Scientific, Keywords also hiked its interim payout by double digits to 0.58p per share. Don’t get excited though – the 1.7p per share analysts expect for the full-year gives a yield of just 0.12%.

There’s been no let-up in the Dublin-based firm’s growth-by-acquisition strategy either, with four businesses purchased over the first half, and another (Berlin-headquartered TV Synchron) announced today. With net debt standing at just €9m, this spending spree is unlikely to end soon.

According to Keywords, trading in H2 so far has been encouraging with the board now predicting “strong organic revenue growth,” albeit a little slower than in H1, as some game developers wait for new games consoles due for release next year. That said, CEO Andrew Day said revenue would still be “at the upper end of current market expectations.”

Unfortunately, it would seem this wasn’t enough reassurance for some, with shares down almost 10% — further proof of just how unforgiving investors can be if companies on already punchy valuations in hot sectors do anything less than outperform (Keywords was trading on a forecast 29 times earnings).

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Paul Summers has no position in any of the stocks mentioned. The Motley Fool UK has recommended Judges Scientific and Keywords Studios. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »